In view of her personal and family history of multiple melanomas, she underwent germline genetic testing following counselling by the clinical genetics team with a melanoma susceptibility gene panel and a variant of uncertain significance in the POT1 gene (c.284 G > T p.(Gly95Val)) was identified. This evidence concerns the gene POT1 and melanoma.